Global Director Pipeline Biosimilar Platform (d/f/m)

Sandoz continues to go through an exciting and transformative period as a global leader and pioneering provider of sustainable biosimilar and generic medicines.

As we continue down this new and ambitious path, unique opportunities will present themselves, both professionally and personally.

In this role you’ll shape the future of our global biosimilar pipeline.

As Global Director Pipeline Biosimilar Platform, you’ll sit at the crossroads of science, commercial strategy, and investment decisions—helping determine which biosimilar assets we invest in, when, and at what scale.

You’ll work closely with commercial, R&D, regulatory, market access, manufacturing, and competitive intelligence teams to ensure our portfolio choices are scientifically sound, commercially attractive, and aligned with long‑term strategy.

In a fast‑evolving biosimilar landscape with shorter lifecycles and shifting global dynamics, you’ll help keep us ahead of the curve and deliberate in where we place our bets.

Key Responsibilities Shaping global biosimilar pipeline strategy, including molecule/platform selection and portfolio balancing.

Building differentiated perspectives on emerging technologies, disease trends, and global market evolution.

Driving rigorous forecasting, valuation, and scenario planning—incorporating development risk, commercial uncertainty, IP dynamics, and competitive threat modelling.

Providing senior leadership with transparent, evidence‑based investment cases.

Navigating increasing scientific and commercial complexity driven by new therapeutic modalities and expanding target spaces.

Ensuring adaptability to regulatory shifts, policy changes, and evolving standards of care—protecting investment decisions and maximizing the value of future launches.

Guiding early commercial strategy, including competitive Target Product Profile development.

What You’ll Bring to the Role A business and/or science background and degree is required.

MD, science Ph D, MBA or equivalent experience is desirable.

Minimum 12 years pharma industry expertise required.

Strong specialty care and biologics background (oncology, immunology, rare diseases).

Ability to integrate scientific assessments, market trends, competitive threats, and evolving policy landscapes into clear strategic recommendations.

Expertise in shaping future‑ready portfolios, including molecule/platform selection, portfolio balancing, and prioritization.

Ability to project commercial potential, design competitive TPPs, and anticipate unmet needs or access barriers.

Demonstrated expertise in portfolio strategy, forecasting, valuation, and risk assessment.

Extensive commercial experience in global or major markets.

Experience leading cross‑functional teams and influencing senior decision making.

Direct people leadership experience preferred.

Strong communicator, capable of presenting complex decisions and recommendations to executive committees with clarity and conviction.

Fluent English (written and spoken).

Additional languages are beneficial.

Benefits Access to Coursera and other learning platforms with more than 200,000 learning videos and 5000+ courses. 30 days of annual leave.

Holiday allowance.

Additional rewards for special occasions (service length awards, marriage celebration, etc.).

Company pension schemes and capital formation benefits.

Parental leave.

Other offerings, such as bike leasing.

Commitment to Diversity & Inclusion We are committed to building an outstanding, inclusive work environment and diverse teams representative of the patients and communities we serve.

Hiring decisions are only based on the qualification for the position, regardless of gender, ethnicity, religion, sexual orientation, age and disability.

The law provides for severely disabled / equal applicants the opportunity to involve the local representative body for disabled employees in the application process; if you would like to request this, please let us know in advance as a note on your CV. #J-18808-Ljbffr